Iran vs Türkiye: Share of men and women expected to survive to the age of 65
Iran
90.2%
in 2024
Türkiye
90.5%
in 2024
Iran rank
63rd
Türkiye rank
60th
Share of men and women expected to survive to the age of 65 over time
- Iran
- Türkiye
How they compare
Türkiye currently reports 90.5% against 90.2% in Iran, a difference of 0.3%.
The two have swapped places 2 times across 65 shared years of data; in 1960 it was Türkiye ahead.
Iran ranks 63rd and Türkiye ranks 60th of 215 countries.
Türkiye has averaged higher in every one of the 7 decades both report.
Head to head by decade
| Decade | Iran | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 1960s | 38.5% | 59.0% | 20.5% | Türkiye |
| 1970s | 51.5% | 66.3% | 14.8% | Türkiye |
| 1980s | 66.1% | 73.9% | 7.8% | Türkiye |
| 1990s | 75.7% | 80.3% | 4.6% | Türkiye |
| 2000s | 83.0% | 85.9% | 2.9% | Türkiye |
| 2010s | 87.6% | 89.6% | 2.0% | Türkiye |
| 2020s | 87.9% | 89.9% | 2.0% | Türkiye |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of men and women expected to survive to the age of 65, Iran or Türkiye?
- Türkiye, at 90.5% against 90.2% in Iran as of 2024.
- What is the difference in share of men and women expected to survive to the age of 65 between Iran and Türkiye?
- 0.3%, with Türkiye ahead.
- How many years of comparable data are there for Iran and Türkiye?
- 65 years are reported by both, from 1960 to 2024.
- How do Iran and Türkiye rank globally for share of men and women expected to survive to the age of 65?
- Iran ranks 63rd and Türkiye ranks 60th of 215 countries.
- Where does this data come from?
- United Nations Population Division (World Population Prospects), via World Bank (2026) – processed by Our World in Data, published as Share of men and women expected to survive to the age of 65. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This measure shows the share newborns that would survive to the age of 65 if subject to the current age specific mortality rates.